News About: Pharm. Industry
There were 452 patent extension applications for pharmaceutical products, causing KRW 3 trillion profits
It is observed that the market profits of original pharmaceutical products – that is, generated through patent extension of newly registered pharmaceutical products – have exceeded approximately KRW 3 trillion. The ca...
Domestic and multinational pharmaceutical companies have begun countdowns in the DDP-4 type anti-diabetes treatment market
DDP-4 (dipeptidyl peptidase-4) inhibitors, leading the diabetes treatment market, are expected to be shaken. Launched of DPP-4 inhibitor-type new drugs, such as adjusted lineup extensions, will be made.
Although the ...
While Champix is in the process of the insurance benefit, other OTC supplements are looking for chances
While the government has confirmed to apply the National Health Insurance in antismoking treatments in the second half of the year, its related treatments have actively been planning to register the program.
Accordin...
The co-developed new anticancer drug by the government and Hanmi will be exported to a U.S. pharmaceutical company
The Ministry of Health and Welfare unveiled on the 5th that it exported the technology of a new anticancer substance (Poziotinib), which has co-developed by a private company and the government, to a anticancer develo...
“Xeljanx is expected to overcome the limitation of rheumarthritis treatments”
As the first oral treatment for rheumarthritis, Xeljanz, has been launched, it is noticed that a new era has been opened in the rheumarthritis treatment market.
Pfizer Korea announced the launch of the oral rheumarth...
Abbott Korea, exclusively owning Ganaton, will make direct marketing in the Korean market
Abbott Korea has acquired the selling rights of the indigestion treatment, Ganaton, and will conduct direct marketing in the Korean market.
According to the company on the 5th, as the license agreement of Ganaton wit...
Most professional managers expiring terms of services in pharmaceutical companies will be reappointed
Shareholders’ general meetings of listed pharmaceutical companies will be held either on 20 and 27 March.
Through recent public announcements, listed pharmaceutical companies spoke that many of them will hold shareho...
The NHIS has raised the damage to KRW 1.2 billion for the GSK and Dong-A ST’s price fixing
The National Health Insurance Service (NHIS) recomputed damages at KRW 1.2 billion for the lawsuit against GlaxoSmithKline and Dong-A ST that has fixed the price of the antiemetic treatment ‘Ondaron’.
“GSK and Dong-A...
Pharmaceutical sales on January were KRW 1.475 trillion, growing 4.8% up compared to the last year
It is known that sales of pharmaceutical products on the last January increased 4.8% up with KRW 1.475 trillion compared to the last year.
Shinhan Investment Corp. unveiled through its analysis report on the 3rd that...
President Park stated “Followed by the Middle East, the next new market is Latin America for the pharmaceutical industry”
While touring the Middle East, President Guen-hye Park is scheduled to visit Latin America next month; thus, it is noticed whether the healthcare industry will earn a beneficial result from the president.
According t...
